Pharmaceutical group

Orphelia

8 medicines3 countries

A group of 5 companies with 8 medicines in 3 countries.

Group structure

5 companies in 0 countries

Headquarters not stated5

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

8 medicines

Medicine	Substance	Country	Status	Authorised
Kigabeq	Vigabatrin	EU (EMA)	Authorised	2018
KIGABEQ 100 MG COMPRIMIDOS SOLUBLES100 mg · Comprimido soluble	Vigabatrin	Spain	Authorised	2021
KIGABEQ 100 mg, oplosbare tabletOplosbare tablet	Vigabatrin	Netherlands	Authorised	2018
KIGABEQ 500 MG COMPRIMIDOS SOLUBLES500 mg · Comprimido soluble	Vigabatrin	Spain	Authorised	2021
KIGABEQ 500 mg, oplosbare tabletOplosbare tablet	Vigabatrin	Netherlands	Authorised	2018
Ivozall	Clofarabine	EU (EMA)	Withdrawn	2019
IVOZALL 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG1 mg/ml · Concentrado para solución para perfusión	Clofarabine	Spain	Withdrawn	2021
Kizfizo	Temozolomide	EU (EMA)	Refused

Sources and licences

Country	Medicines	Current	Past	Companies
Spain	3	2	1	Companies All medicines
European Union (EMA)	3	1	2	Companies All medicines
Netherlands	2	2	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

All 11 sources

BDPM / ANSM, HAS and UNCAM, France

BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Report an error or request removal Corrections from the company itself are welcome.

Orphelia

Group structure

Headquarters not stated5

Medicines

Know your medicines, with the sources.

Orphelia

Group structure

Headquarters not stated5

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Sources and licences

At a glance

Work with Prognia

Other big groups